A pocket guide on how to structure SARS-CoV-2 drugs and therapies

Dene R. Littler, Bruce J. MacLachlan, Gabrielle M. Watson, Julian P. Vivian, Benjamin S. Gully

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

The race to identify a successful treatment for COVID19 will be defined by fundamental research into the replication cycle of the SARS-CoV-2 virus. This has identified five distinct stages from which numerous vaccination and clinical trials have emerged alongside an innumerable number of drug discovery studies currently in development for disease intervention. Informing every step of the viral replication cycle has been an unprecedented 'call-to-arms' by the global structural biology community. Of the 20 main SARS-CoV-2 proteins, 13 have been resolved structurally for SARS-CoV-2 with most having a related SARS-CoV and MERS-CoV structural homologue totalling some 300 structures currently available in public repositories. Herein, we review the contribution of structural studies to our understanding of the virus and their role in structure-based development of therapeutics.

Original languageEnglish
Pages (from-to)2625-2641
Number of pages17
JournalBiochemical Society Transactions
Volume48
Issue number6
DOIs
Publication statusPublished - Dec 2020

Cite this